11/20/2023
SynCeD Study: Phase 2a Clinical Trial Now Enrolling
The SynCeD Study is looking for adult volunteers with celiac disease to join a phase 2a clinical trial. Your participation could make a difference.
Continue ReadingFeatured News
Tag: news feed
1/4/2023
New At-Home Celiac Disease Research Study
Consider joining the CeDar Rose Study, a remote celiac disease study that will monitor individual gluten tolerance.
Continue Reading1/28/2021
Senate Releases FY2021 Language Directing NIH to Study Celiac Disease
The Senate Appropriations Committee has released their FY2021 funding recommendations, which includes report language directing NIH to support celiac disease research.
Continue Reading11/19/2020
Patients Who Have Participated In a Celiac Disease Clinical Trial Needed for 2021 Patient Education & Advocacy Summit
Patients Who Have Participated In a Celiac Disease Clinical Trial Needed for 2021 Patient Education & Advocacy Summit.
Continue Reading10/26/2020
iCureCeliac Study Wins Outstanding Poster Presenter Award at 2020 ACG Meeting
A study led by Columbia University and Celiac Disease Foundation researchers examined probiotic use among celiac disease patients and was an Outstanding Poster Presenter recipient at the 2020 ACG Annual Scientific Meeting.
Continue ReadingRecent Posts
- Exploring the Intersection of Nutrition Science and Policy: Highlights from the NIH-FDA Workshop
- Challenges Persist for Students with Celiac Disease in Free School Meal Programs
- Please Join Us for the Teal Pumpkin Project 2024!
- Why Aren't Most Rice Krispy Treats Gluten-Free?
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Research News
- Research Press
- Trending Topics
Marilyn's Message
9/26/2024
Read more2024 International Celiac Disease Symposium Recap
Last month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...